SWISS NUCLIDES
Swiss Nuclides, a 2018 founded startup based in Aarau (Aargau), has made it its mission to develop precision diagnostic tools for cancer that are better, safe, more affordable, and accessible by every cancer patient.
SWISS NUCLIDES
Social Links:
Industry:
Health Care Health Diagnostics
Founded:
2018-01-01
Address:
Aarau, Aargau, Switzerland
Country:
Switzerland
Website Url:
http://www.swissnuclides.ch
Total Employee:
1+
Status:
Active
Contact:
+41 78 326 6666
Email Addresses:
[email protected]
Total Funding:
2.6 M CHF
Technology used in webpage:
Microsoft Azure DNS One.com DNS
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
epilab
epilab is a developer of a portable screening test for tuberculosis, to diagnose.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Healthily
Healthily is the world’s first medically approved self-care app designed around you.
Current Employees Featured
Founder
Investors List
Turos Capital
Turos Capital investment in Series A - Swiss Nuclides
Official Site Inspections
http://www.swissnuclides.ch
- Host name: webcluster1.webpod12-cph3.one.com
- IP address: 46.30.213.31
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Swiss Nuclides"
Swiss Nuclides - Crunchbase Company Profile & Funding
Swiss Nuclides is a developer of a novel radionuclide PET tracers for the precision diagnostics.See details»
Swiss Nuclides - 2025 Company Profile - Tracxn
Apr 28, 2025 Swiss Nuclides is a seed company based in Aarau (Switzerland), founded in 2017 by Gustav von Schulthess. It operates as a Developer of radionuclide PET tracers for …See details»
Nuclidium - Products, Competitors, Financials, Employees, …
About Nuclidium Nuclidium is a company focused on developing best-in-class copper-based radiopharmaceuticals for the precision oncology industry. Their main offerings include a …See details»
Nuclidium (Swiss Nuclides AG) - startupticker.ch
Feb 8, 2021 More news about Nuclidium (Swiss Nuclides AG)21.10.2024 17:00See details»
NUCLIDIUM AG Overview | SignalHire Company Profile
Nuclidium is setting a new standard in the precision oncology landscape by developing best-in-class copper-based radiopharmaceuticals that enable the highest accuracy and accessibility …See details»
Swiss Nuclides | Qodeo
Pitch Financials Investors Overview About Pitch Financials Investors Overview Organization Details Organization Registered Name Elevator PitchSwiss NuclidesSee details»
Nuclidium AG :: Switzerland :: OpenCorporates
Free and open company data on Switzerland company Nuclidium AG (company number 1298847), Bäumleingasse, 18, Im Erasmushaus, Basel, 4051See details»
Swiss Nuclides Gmbh | Aarau | Thibaut Denoël - AllBiz
Thibaut Denoël ist der Hauptkontakt bei Swiss Nuclides Gmbh. Swiss Nuclides Gmbh hat seinen Sitz in Aarau.See details»
Swiss Nuclides AG - startup.ch
Funding News Milestones Jobs Videos and documents Awards Only registered users have access to funding information.Swiss Nuclides AG:See details»
Swiss Nuclides - Funding, Financials, Valuation & Investors
Swiss Nuclides is a developer of a novel radionuclide PET tracers for the precision diagnostics.See details»
Swiss Nuclides - Overview, News & Competitors | ZoomInfo.com
View Swiss Nuclides (www.swissnuclides.ch) location in Aargau, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Nuclidium AG, Basel | Entscheidungsträger - business-monitor.ch
Nuclidium AG, Schweizer Unternehmen, mit Sitz in Basel - Liste der Entscheidungsträger, Rolle, Herkunft, Wohnsitz und Dauer des Executive-MandatsSee details»
Swiss Nuclides raises CHF 2.6m in Series A Financing
23 June 2021 - Swiss Nuclides AG, a developer of novel radionuclide PET tracers for the precision diagnostics, has raised CHF 2.6m.See details»
Swiss Nuclides to enable precision cancer diagnosis
Feb 8, 2021 Swiss Nuclides AG, a developer of a novel radionuclide PET tracers for the precision diagnostics closed the first closing of its Series A financing, raising CHF 2.6 million …See details»
Swiss Nuclides AG - startup.ch
Quick links Investors Tools for startups TOP 100 Swiss Startup Award About startup.ch Your company is not listed?See details»
Swiss Nuclides - Contacts, Employees, Board Members
Swiss Nuclides is a developer of a novel radionuclide PET tracers for the precision diagnostics.See details»
Swiss nuclides gmbh Reviews | Read Client Reviews of Swiss …
Read reviews of Swiss nuclides gmbh. Write and share your personal story. Your experience will help others make the right buying decision.See details»
Series A - Swiss Nuclides - 2021-08-02 - Crunchbase
Swiss Nuclides raised $2872278 on 2021-08-02 in Series ASee details»
Swiss Nuclides Gmbh | Aarau | Thibaut Denoël - AllBiz
Thibaut Denoël est le contact principal chez Swiss Nuclides Gmbh. Swiss Nuclides Gmbh se trouve a Aarau.See details»
Swiss Nuclides Gmbh Email, Phone Number, Employees, …
Aarau, Aargau, Switzerland Get Verified Emails of 5 Swiss Nuclides Gmbh Employees Industry Medical Devices Website swissnuclides.ch Location Aarau, Aargau, Switzerland Employees 5 …See details»